TO · IGX.TO
IntelGenx Technologies Corp.
- Sector
- Healthcare · Biotechnology
- Headquarters
- Montreal, QC H4S 1Y2
- Website
- intelgenx.com
Price at previous close
$0.24
Market cap 41.92M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2009 | $0.00 | $0.00 | |||
| 2010 | $0.00 | $0.00 | |||
| 2011 | $0.00 | $4.30 | |||
| 2012 | $0.00 | $0.00 | |||
| 2013 | $0.00 | $0.50 | |||
| 2014 | $0.00 | $0.00 | |||
| 2015 | $0.30 | $5.80 | |||
| 2016 | $0.00 | $0.00 | |||
| 2017 | $0.00 | $0.00 | |||
| 2018 | $0.00 | $10.10 | |||
| 2019 | $0.00 | $7.70 | |||
| 2020 | $0.00 | $0.00 | |||
| 2021 | $0.00 | $0.00 | |||
| 2022 | $0.00 | $2.50 | |||
About IntelGenx Technologies Corp.
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.
- CEO
- Dwight Gorham
- Employees
- 0
- Beta
- 2.54
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $0.24) − 1 = — (DCF, example).